Volume 85, Issue 1, Pages (January 2014)

Slides:



Advertisements
Similar presentations
Volume 78, Issue 11, Pages (December 2010)
Advertisements

The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis  Padmavathi devi Nalapareddy, Sven Schüngel,
Treatment of Dermal Fibroblasts with GPI-Anchored Human TIMP-1 Protein Moderates Processes Linked to Scar Formation  Roghieh Djafarzadeh, Susan Notohamiprodjo,
Volume 77, Issue 6, Pages (March 2010)
Volume 78, Issue 3, Pages (August 2010)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling
Volume 66, Issue 4, Pages (October 2004)
Plasmin is not protective in experimental renal interstitial fibrosis1
HDAC Dependent Transcriptional Repression of Bmp-7 Potentiates TGF-β Mediated Renal Fibrosis in Obstructive Uropathy  Scott R. Manson, Joseph B. Song,
Inhibition of ILK by QLT-0267 suppresses type I and type III collagen expression and ameliorates interstitial collagen deposition and renal fibrosis after.
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 85, Issue 2, Pages (January 2014)
Volume 78, Issue 4, Pages (August 2010)
G.-T. Shin, D.R. Kim, J.-E. Lim, H. Yim, H. Kim  Kidney International 
Volume 82, Issue 6, Pages (September 2012)
Jinu Kim, Kelly E. Long, Kang Tang, Babu J. Padanilam 
Volume 87, Issue 4, Pages (April 2015)
Volume 82, Issue 8, Pages (October 2012)
Volume 67, Issue 3, Pages (March 2005)
Volume 84, Issue 2, Pages (August 2013)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 86, Issue 3, Pages (September 2014)
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 88, Issue 3, Pages (September 2015)
Volume 84, Issue 1, Pages (July 2013)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 79, Issue 3, Pages (February 2011)
Volume 58, Issue 2, Pages (August 2000)
Expression of HIV transgene aggravates kidney injury in diabetic mice
Paricalcitol attenuates cyclosporine-induced kidney injury in rats
Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury  Dong Zhou, Roderick.
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Volume 78, Issue 2, Pages (July 2010)
Volume 79, Issue 7, Pages (April 2011)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Autophagy in proximal tubules protects against acute kidney injury
Volume 81, Issue 3, Pages (February 2012)
Volume 81, Issue 12, Pages (June 2012)
Volume 84, Issue 2, Pages (August 2013)
Volume 83, Issue 4, Pages (April 2013)
Volume 84, Issue 5, Pages (November 2013)
Volume 81, Issue 5, Pages (March 2012)
Volume 73, Issue 4, Pages (February 2008)
Volume 60, Issue 2, Pages (August 2001)
Prolonged Activation of ERK Contributes to the Photorejuvenation Effect in Photodynamic Therapy in Human Dermal Fibroblasts  Yong Hyun Jang, Gi-Bang Koo,
Volume 82, Issue 4, Pages (August 2012)
Volume 78, Issue 11, Pages (December 2010)
Volume 69, Issue 2, Pages (January 2006)
Volume 83, Issue 3, Pages (March 2013)
Volume 92, Issue 3, Pages (September 2017)
Volume 79, Issue 4, Pages (February 2011)
Volume 76, Issue 5, Pages (September 2009)
Genetic deficiency of adiponectin protects against acute kidney injury
Chi-Hyun Park, Youngji Moon, Chung Min Shin, Jin Ho Chung 
Volume 85, Issue 4, Pages (April 2014)
Volume 85, Issue 2, Pages (January 2014)
Volume 78, Issue 7, Pages (October 2010)
Volume 76, Issue 7, Pages (October 2009)
Heat Shock-Induced Matrix Metalloproteinase (MMP)-1 and MMP-3 Are Mediated through ERK and JNK Activation and via an Autocrine Interleukin-6 Loop  Chi-Hyun.
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 67, Issue 6, Pages (June 2005)
Smad3 and Extracellular Signal-Regulated Kinase 1/2 Coordinately Mediate Transforming Growth Factor-β-Induced Expression of Connective Tissue Growth Factor.
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Volume 76, Issue 8, Pages (October 2009)
Volume 21, Issue 2, Pages (February 2013)
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 65, Issue 1, Pages (January 2004)
Volume 85, Issue 1, Pages (January 2014)
Presentation transcript:

Volume 85, Issue 1, Pages 82-93 (January 2014) TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury  Zuocheng Wang, Konrad Famulski, Jiwon Lee, Subhash K. Das, Xiuhua Wang, Philip Halloran, Gavin Y. Oudit, Zamaneh Kassiri  Kidney International  Volume 85, Issue 1, Pages 82-93 (January 2014) DOI: 10.1038/ki.2013.225 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Loss of tissue inhibitor of metalloproteinase-2 (TIMP2) or TIMP3 differentially alters gene expression in kidneys at 3 days after unilateral urethral obstruction (UUO). (a) Hierarchical clustering of interquartile range (IQR)–filtered transcripts showing global changes in gene expression. Similarity measure was the Euclidean distance and clustering algorithm was average linkage, as implemented in GeneSpring 7.3. Branch lengths represent the degree of similarity; blue, red, and green tiles indicate no changes, increase, and decrease in expression, respectively. UUO samples were normalized to their sham controls. (b) Total number of genes unique to TIMP2−/− and TIMP3−/− or overlapping with wild-type (WT) in sham (top) or 3 days after UUO (bottom). Averaged expression of (c) intermediate and late injury- and repair-induced transcripts (IRITD3 and IRITD5), and (d) kidney selective transcript (KT1) and solute carrier genes (KT2) in WT, TIMP2−/−, and TIMP3−/− kidneys after sham or UUO. n=8/genotype/group. *P<0.05 compared with corresponding sham; #P<0.05 compared with TIMP2−/− UUO. PBT, pathogenesis-based transcript set. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Loss of tissue inhibitor of metalloproteinase-2 (TIMP2) or TIMP3 affects early gene expression in kidneys at 3 days after unilateral urethral obstruction (UUO). Expression of (a) primary macrophage–associated transcripts (PMATs) and early injury- and repair-induced transcripts (IRITD1), and (b) cytotoxic T cell–associated transcripts (CAT1, formerly CAT) and interferon-γ and rejection-induced transcripts reflecting IFNG effect (GRIT1, formerly tGRIT) in wild-type (WT), TIMP2−/−, and TIMP3−/− kidneys after sham or UUO. n=8/genotype/group. *P<0.05 compared with the corresponding sham group. #P<0.05 compared with WT UUO. IFNG, interferon gamma; PBT, pathogenesis-based transcript set. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Loss of tissue inhibitor of metalloproteinase-3 (TIMP3), but not of TIMP2, activates tumor necrosis factor-α (TNFα)–converting enzyme (TACE), caspase-3, and mitogen-activated protein kinase (MAPK) signaling pathways at 3 days after unilateral urethral obstruction (UUO). (a) Representative western blots and averaged protein content of phosphorylated (p-TACE) and total TACE in the membrane protein fraction. Na+/K+-ATPase was used as loading control for the membrane fraction. The quality of membrane fractionation can be further referred to in Supplementary Figure S1c online. (b) Representative western blots and averaged protein content of cleaved and total caspase-3. (c) Representative TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining. Arrows indicate apoptotic cells. Scale bar=50μm. (d) Representative western blots and averaged protein content of phospho- and total levels of extracellular signal–regulated kinase (ERK1/2) and c-Jun N-terminal kinase (JNK1/2) in the kidneys of indicated groups after sham or UUO. n=5/genotype/group; *P<0.05 versus corresponding sham; #P<0.05 versus WT and TIMP2−/− UUO groups. AU, arbitrary unit. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Histological analysis and second harmonic generation (SHG) imaging showing increased tubulointerstitial fibrosis and disrupted extracellular matrix in tissue inhibitor of metalloproteinase-3 (TIMP3)–deficient kidneys after unilateral urethral obstruction (UUO). (a) Light microscopy of periodic acid–Schiff (PAS)–stained, and fluorescent microscopy of picrosirius red (PSR)–stained, formalin-fixed kidney sections after 3 days of UUO. Scale bar=50μm. (b) SHG and multiphoton excitation fluorescence (MPEF) imaging in unfixed and unstained kidneys showing the fibrillar collagen network (magenta) and tubular endogenous autofluorescence (green) in wild-type (WT) and TIMP3−/− kidneys at 3 days after UUO. Scale bar=80μm. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Differential impact of tissue inhibitor of metalloproteinase-3 (TIMP3) versus TIMP2 loss on mRNA expression of profibrotic mediators, and on matrix metalloproteinase-2 (MMP2) activation. mRNA expression levels of (a) collagen I and III, (b) connective tissue growth factor (CTGF), and transforming growth factor-β (TGFβ) by TaqMan real-time PCR in wild-type (WT), TIMP2−/−, and TIMP3−/− kidneys 3 days after sham or unilateral urethral obstruction (UUO). (c) Representative gelatin zymography (i) and averaged band intensities for MMP9 (90kDa) (ii), pro-MMP2 (72kDa) (iii), and cleaved MMP2 (64kDa) (iv), in the indicated groups. +ve Ctrl, positive control. Coomassie blue–stained gel is shown as the loading control. n=8/genotype/group; *P<0.05 versus corresponding sham; #P<0.05 versus WT-UUO group. AU, arbitrary unit. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 6 Loss of tissue inhibitor of metalloproteinase-2 (TIMP2) suppressed the activation of the transforming growth factor-β (TGFβ) signaling pathway after unilateral urethral obstruction (UUO). (a) Representative western blots for (i) latent TGFβ (45kDa), mature TGFβ (25kDa), phosphorylated and total Smad2/3 (60/52kDa), and averaged protein content for (ii) latent TGFβ, (iii) mature TGFβ, and (iv) p-Smad-to-total Smad ratio in the indicated groups at 3 days after sham or UUO. (b) Representative western blots on nuclear protein fraction showing Smad4 levels. Averaged nuclear Smad4 level in the indicated group is shown in the bar graph. A nucleus-specific protein (Histone H3) and a cytosol-specific protein (caspase-3) were used to demonstrate protein fractionation efficacy. The quality of nuclear fractionation can be further referred to in Supplementary Figure S1c online. *P<0.05 versus corresponding sham; #P<0.05 versus WT-UUO. AU, arbitrary unit; WT, wild type. n=6/genotype/group. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 7 Tissue inhibitor of metalloproteinase-2 (TIMP2) deficiency attenuates tubulointerstitial fibrosis after unilateral urethral obstruction (UUO). (a) Picrosirius red (PSR)–stained sections visualized by fluorescent microscopy, and averaged collagen volume fraction in TIMP2−/− kidneys at 14 days after UUO (14d-UUO) compared with parallel sham and wild-type (WT) group. Scale bar=50μm. (b) Trichrome-stained and light microscopy of WT and TIMP2−/− kidneys at 14 days after sham or UUO. Scale bar=100μm. (c) Representative western blot and averaged protein content of collagen I and collagen III in TIMP2−/−-UUO compared with WT-UUO kidneys at 14 days after UUO. n=5/genotype/group. *P<0.05 versus corresponding sham; #P<0.05 versus WT-UUO. Kidney International 2014 85, 82-93DOI: (10.1038/ki.2013.225) Copyright © 2014 International Society of Nephrology Terms and Conditions